# FDA Inspection 1315522 - Summit Therapeutics, Inc. - April 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/summit-therapeutics-inc/e674ab87-2293-45ca-9d8d-639ba5341556
Source feed: FDA_Inspections

> FDA Inspection 1315522 for Summit Therapeutics, Inc. on April 10, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1315522
- Company Name: Summit Therapeutics, Inc.
- Inspection Date: 2026-04-10
- Product Type: Human Drugs
- Office Name: San Francisco District Office

Company: https://www.keypedia.com/companies/summit-therapeutics-inc/6717ca4e-4049-414c-b9af-3028150c88dc

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df